A team of Queensland researchers has begun an ambitious race to develop a vaccine for a rare but potentially fatal virus in just 150 days, according to a statement released by the University of Queensland on Wednesday. UQ’s Vaccine Rapid Response Team is testing its capabilities by creating a vaccine for the Bolivian Chapare virus,…
Brisbane-based clinical-stage biotechnology company Vaxxas secured a new patent from the United States patent office covering its proprietary manufacturing technology for needle-free vaccine patches, the company announced on Wednesday. The patent covers Vaxxas’ printhead system that dispenses dried vaccine formulations onto the company’s high-density microarray patch (HD-MAP), which features thousands of microscopic projections on a…
Brisbane-based biotechnology company Vaxxas published new research on Wednesday showing promising results for its needle-free vaccine delivery technology. The company’s high-density microarray patch (HD-MAP) – a small patch containing thousands of tiny projections coated with vaccine – successfully delivered a DNA-based COVID-19 vaccine in animal testing, according to research published in the science journal Heliyon.…
